Product Code: TMRGL83568
The report provides revenue of the global insufflation devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global insufflation devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the insufflation devices market.
The report delves into the competitive landscape of the global insufflation devices market. Key players operating in the global insufflation devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global insufflation devices market profiled in this report.
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Investment Feasibility Matrix
- 3.4. Value Chain Analysis
- 3.5. Regulatory Landscape
- 3.5.1. By Key Regions
- 3.5.2. By Key Countries
4. Global Insufflation Devices Market Analysis 2017-2021 and Forecast, 2022-2032
- 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
- 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
5. Global Insufflation Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Application
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
- 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
- 5.3.1. Laparoscopic Surgery
- 5.3.2. Bariatric Surgery
- 5.3.3. Cardiac Surgery
- 5.3.4. Other Surgeries
- 5.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
- 5.5. Absolute $ Opportunity Analysis By Application, 2022-2032
6. Global Insufflation Devices Market Analysis 2017-2021 and Forecast 2022-2032, By End User
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
- 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
- 6.3.1. Hospitals
- 6.3.2. Clinics
- 6.3.3. Ambulatory Surgical Centers
- 6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
- 6.5. Absolute $ Opportunity Analysis By End User, 2022-2032
7. Global Insufflation Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Region
- 7.1. Introduction
- 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
- 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
- 7.3.1. North America
- 7.3.2. Latin America
- 7.3.3. Europe
- 7.3.4. East Asia
- 7.3.5. South Asia
- 7.3.6. Oceania
- 7.3.7. MEA
- 7.4. Market Attractiveness Analysis By Region
8. North America Insufflation Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 8.2.1. By Country
- 8.2.1.1. U.S.
- 8.2.1.2. Canada
- 8.2.2. By Application
- 8.2.3. By End User
- 8.3. Market Attractiveness Analysis
- 8.3.1. By Country
- 8.3.2. By Application
- 8.3.3. By End User
- 8.4. Key Takeaways
9. Latin America Insufflation Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 9.2.1. By Country
- 9.2.1.1. Brazil
- 9.2.1.2. Mexico
- 9.2.1.3. Argentina
- 9.2.1.4. Rest of Latin America
- 9.2.2. By Application
- 9.2.3. By End User
- 9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Application
- 9.3.3. By End User
- 9.4. Key Takeaways
10. Europe Insufflation Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 10.2.1. By Country
- 10.2.1.1. Germany
- 10.2.1.2. Italy
- 10.2.1.3. France
- 10.2.1.4. U.K.
- 10.2.1.5. Spain
- 10.2.1.6. Russia
- 10.2.1.7. BENELUX
- 10.2.1.8. Rest of Europe
- 10.2.2. By Application
- 10.2.3. By End User
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Application
- 10.3.3. By End User
- 10.4. Key Takeaways
11. East Asia Insufflation Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 11.2.1. By Country
- 11.2.1.1. China
- 11.2.1.2. Japan
- 11.2.1.3. South Korea
- 11.2.2. By Application
- 11.2.3. By End User
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Application
- 11.3.3. By End User
- 11.4. Key Takeaways
12. South Asia Insufflation Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 12.2.1. By Country
- 12.2.1.1. India
- 12.2.1.2. Thailand
- 12.2.1.3. Malaysia
- 12.2.1.4. Indonesia
- 12.2.1.5. Rest of South Asia
- 12.2.2. By Application
- 12.2.3. By End User
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Application
- 12.3.3. By End User
- 12.4. Key Takeaways
13. Oceania Insufflation Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 13.2.1. By Country
- 13.2.1.1. Australia
- 13.2.1.2. New Zealand
- 13.2.2. By Application
- 13.2.3. By End User
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Application
- 13.3.3. By End User
- 13.4. Key Takeaways
14. MEA Insufflation Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 14.2.1. By Country
- 14.2.1.1. GCC
- 14.2.1.2. Rest of MEA
- 14.2.2. By Application
- 14.2.3. By End User
- 14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Application
- 14.3.3. By End User
- 14.4. Key Takeaways
15. Key Countries Insufflation Devices Market Analysis
- 15.1. U.S.
- 15.1.1. Pricing Analysis
- 15.1.2. Market Share Analysis, 2021
- 15.1.2.1. By Application
- 15.1.2.2. By End User
- 15.2. Canada
- 15.2.1. Pricing Analysis
- 15.2.2. Market Share Analysis, 2021
- 15.2.2.1. By Application
- 15.2.2.2. By End User
- 15.3. Brazil
- 15.3.1. Pricing Analysis
- 15.3.2. Market Share Analysis, 2021
- 15.3.2.1. By Application
- 15.3.2.2. By End User
- 15.4. Mexico
- 15.4.1. Pricing Analysis
- 15.4.2. Market Share Analysis, 2021
- 15.4.2.1. By Application
- 15.4.2.2. By End User
- 15.5. Argentina
- 15.5.1. Pricing Analysis
- 15.5.2. Market Share Analysis, 2021
- 15.5.2.1. By Application
- 15.5.2.2. By End User
- 15.6. Germany
- 15.6.1. Pricing Analysis
- 15.6.2. Market Share Analysis, 2021
- 15.6.2.1. By Application
- 15.6.2.2. By End User
- 15.7. Italy
- 15.7.1. Pricing Analysis
- 15.7.2. Market Share Analysis, 2021
- 15.7.2.1. By Application
- 15.7.2.2. By End User
- 15.8. France
- 15.8.1. Pricing Analysis
- 15.8.2. Market Share Analysis, 2021
- 15.8.2.1. By Application
- 15.8.2.2. By End User
- 15.9. U.K.
- 15.9.1. Pricing Analysis
- 15.9.2. Market Share Analysis, 2021
- 15.9.2.1. By Application
- 15.9.2.2. By End User
- 15.10. Spain
- 15.10.1. Pricing Analysis
- 15.10.2. Market Share Analysis, 2021
- 15.10.2.1. By Application
- 15.10.2.2. By End User
- 15.11. Russia
- 15.11.1. Pricing Analysis
- 15.11.2. Market Share Analysis, 2021
- 15.11.2.1. By Application
- 15.11.2.2. By End User
- 15.12. BENELUX
- 15.12.1. Pricing Analysis
- 15.12.2. Market Share Analysis, 2021
- 15.12.2.1. By Application
- 15.12.2.2. By End User
- 15.13. China
- 15.13.1. Pricing Analysis
- 15.13.2. Market Share Analysis, 2021
- 15.13.2.1. By Application
- 15.13.2.2. By End User
- 15.14. Japan
- 15.14.1. Pricing Analysis
- 15.14.2. Market Share Analysis, 2021
- 15.14.2.1. By Application
- 15.14.2.2. By End User
- 15.15. South Korea
- 15.15.1. Pricing Analysis
- 15.15.2. Market Share Analysis, 2021
- 15.15.2.1. By Application
- 15.15.2.2. By End User
- 15.16. India
- 15.16.1. Pricing Analysis
- 15.16.2. Market Share Analysis, 2021
- 15.16.2.1. By Application
- 15.16.2.2. By End User
- 15.17. Thailand
- 15.17.1. Pricing Analysis
- 15.17.2. Market Share Analysis, 2021
- 15.17.2.1. By Application
- 15.17.2.2. By End User
- 15.18. Malaysia
- 15.18.1. Pricing Analysis
- 15.18.2. Market Share Analysis, 2021
- 15.18.2.1. By Application
- 15.18.2.2. By End User
- 15.19. Indonesia
- 15.19.1. Pricing Analysis
- 15.19.2. Market Share Analysis, 2021
- 15.19.2.1. By Application
- 15.19.2.2. By End User
- 15.20. Australia
- 15.20.1. Pricing Analysis
- 15.20.2. Market Share Analysis, 2021
- 15.20.2.1. By Application
- 15.20.2.2. By End User
- 15.21. New Zealand
- 15.21.1. Pricing Analysis
- 15.21.2. Market Share Analysis, 2021
- 15.21.2.1. By Application
- 15.21.2.2. By End User
- 15.22. GCC Countries
- 15.22.1. Pricing Analysis
- 15.22.2. Market Share Analysis, 2021
- 15.22.2.1. By Application
- 15.22.2.2. By End User
16. Market Structure Analysis
- 16.1. Competition Dashboard
- 16.2. Competition Benchmarking
- 16.3. Market Share Analysis of Top Players
- 16.3.1. By Regional
- 16.3.2. By Application
- 16.3.3. By End User
17. Competition Analysis
- 17.1. Competition Deep Dive
- 17.1.1. Fujifilm
- 17.1.1.1. Overview
- 17.1.1.2. Product Portfolio
- 17.1.1.3. Profitability by Market Segments
- 17.1.1.4. Sales Footprint
- 17.1.1.5. Strategy Overview
- 17.1.1.5.1. Marketing Strategy
- 17.1.1.5.2. Product Strategy
- 17.1.1.5.3. Channel Strategy
- 17.1.2. Medtronic
- 17.1.2.1. Overview
- 17.1.2.2. Product Portfolio
- 17.1.2.3. Profitability by Market Segments
- 17.1.2.4. Sales Footprint
- 17.1.2.5. Strategy Overview
- 17.1.2.5.1. Marketing Strategy
- 17.1.2.5.2. Product Strategy
- 17.1.2.5.3. Channel Strategy
- 17.1.3. Stryker Corporation
- 17.1.3.1. Overview
- 17.1.3.2. Product Portfolio
- 17.1.3.3. Profitability by Market Segments
- 17.1.3.4. Sales Footprint
- 17.1.3.5. Strategy Overview
- 17.1.3.5.1. Marketing Strategy
- 17.1.3.5.2. Product Strategy
- 17.1.3.5.3. Channel Strategy
- 17.1.4. BD
- 17.1.4.1. Overview
- 17.1.4.2. Product Portfolio
- 17.1.4.3. Profitability by Market Segments
- 17.1.4.4. Sales Footprint
- 17.1.4.5. Strategy Overview
- 17.1.4.5.1. Marketing Strategy
- 17.1.4.5.2. Product Strategy
- 17.1.4.5.3. Channel Strategy
- 17.1.5. Olympus
- 17.1.5.1. Overview
- 17.1.5.2. Product Portfolio
- 17.1.5.3. Profitability by Market Segments
- 17.1.5.4. Sales Footprint
- 17.1.5.5. Strategy Overview
- 17.1.5.5.1. Marketing Strategy
- 17.1.5.5.2. Product Strategy
- 17.1.5.5.3. Channel Strategy
- 17.1.6. B. Braun Melsungen
- 17.1.6.1. Overview
- 17.1.6.2. Product Portfolio
- 17.1.6.3. Profitability by Market Segments
- 17.1.6.4. Sales Footprint
- 17.1.6.5. Strategy Overview
- 17.1.6.5.1. Marketing Strategy
- 17.1.6.5.2. Product Strategy
- 17.1.6.5.3. Channel Strategy
- 17.1.7. Smith & Nephew
- 17.1.7.1. Overview
- 17.1.7.2. Product Portfolio
- 17.1.7.3. Profitability by Market Segments
- 17.1.7.4. Sales Footprint
- 17.1.7.5. Strategy Overview
- 17.1.7.5.1. Marketing Strategy
- 17.1.7.5.2. Product Strategy
- 17.1.7.5.3. Channel Strategy
- 17.1.8. Karl Storz
- 17.1.8.1. Overview
- 17.1.8.2. Product Portfolio
- 17.1.8.3. Profitability by Market Segments
- 17.1.8.4. Sales Footprint
- 17.1.8.5. Strategy Overview
- 17.1.8.5.1. Marketing Strategy
- 17.1.8.5.2. Product Strategy
- 17.1.8.5.3. Channel Strategy
- 17.1.9. Steris
- 17.1.9.1. Overview
- 17.1.9.2. Product Portfolio
- 17.1.9.3. Profitability by Market Segments
- 17.1.9.4. Sales Footprint
- 17.1.9.5. Strategy Overview
- 17.1.9.5.1. Marketing Strategy
- 17.1.9.5.2. Product Strategy
- 17.1.9.5.3. Channel Strategy
- 17.1.10. CONMED
- 17.1.10.1. Overview
- 17.1.10.2. Product Portfolio
- 17.1.10.3. Profitability by Market Segments
- 17.1.10.4. Sales Footprint
- 17.1.10.5. Strategy Overview
- 17.1.10.5.1. Marketing Strategy
- 17.1.10.5.2. Product Strategy
- 17.1.10.5.3. Channel Strategy
- 17.1.11. Richard Wolf
- 17.1.11.1. Overview
- 17.1.11.2. Product Portfolio
- 17.1.11.3. Profitability by Market Segments
- 17.1.11.4. Sales Footprint
- 17.1.11.5. Strategy Overview
- 17.1.11.5.1. Marketing Strategy
- 17.1.11.5.2. Product Strategy
- 17.1.11.5.3. Channel Strategy
- 17.1.12. Laprosurge
- 17.1.12.1. Overview
- 17.1.12.2. Product Portfolio
- 17.1.12.3. Profitability by Market Segments
- 17.1.12.4. Sales Footprint
- 17.1.12.5. Strategy Overview
- 17.1.12.5.1. Marketing Strategy
- 17.1.12.5.2. Product Strategy
- 17.1.12.5.3. Channel Strategy
- 17.1.13. LocaMed
- 17.1.13.1. Overview
- 17.1.13.2. Product Portfolio
- 17.1.13.3. Profitability by Market Segments
- 17.1.13.4. Sales Footprint
- 17.1.13.5. Strategy Overview
- 17.1.13.5.1. Marketing Strategy
- 17.1.13.5.2. Product Strategy
- 17.1.13.5.3. Channel Strategy
- 17.1.14. Mindray
- 17.1.14.1. Overview
- 17.1.14.2. Product Portfolio
- 17.1.14.3. Profitability by Market Segments
- 17.1.14.4. Sales Footprint
- 17.1.14.5. Strategy Overview
- 17.1.14.5.1. Marketing Strategy
- 17.1.14.5.2. Product Strategy
- 17.1.14.5.3. Channel Strategy
- 17.1.15. Seeman Technologies
- 17.1.15.1. Overview
- 17.1.15.2. Product Portfolio
- 17.1.15.3. Profitability by Market Segments
- 17.1.15.4. Sales Footprint
- 17.1.15.5. Strategy Overview
- 17.1.15.5.1. Marketing Strategy
- 17.1.15.5.2. Product Strategy
- 17.1.15.5.3. Channel Strategy
- 17.1.16. Cooper Surgical
- 17.1.16.1. Overview
- 17.1.16.2. Product Portfolio
- 17.1.16.3. Profitability by Market Segments
- 17.1.16.4. Sales Footprint
- 17.1.16.5. Strategy Overview
- 17.1.16.5.1. Marketing Strategy
- 17.1.16.5.2. Product Strategy
- 17.1.16.5.3. Channel Strategy
- 17.1.17. Genicom
- 17.1.17.1. Overview
- 17.1.17.2. Product Portfolio
- 17.1.17.3. Profitability by Market Segments
- 17.1.17.4. Sales Footprint
- 17.1.17.5. Strategy Overview
- 17.1.17.5.1. Marketing Strategy
- 17.1.17.5.2. Product Strategy
- 17.1.17.5.3. Channel Strategy
- 17.1.18. Ackermann Instrumente
- 17.1.18.1. Overview
- 17.1.18.2. Product Portfolio
- 17.1.18.3. Profitability by Market Segments
- 17.1.18.4. Sales Footprint
- 17.1.18.5. Strategy Overview
- 17.1.18.5.1. Marketing Strategy
- 17.1.18.5.2. Product Strategy
- 17.1.18.5.3. Channel Strategy
- 17.1.19. Teleflex
- 17.1.19.1. Overview
- 17.1.19.2. Product Portfolio
- 17.1.19.3. Profitability by Market Segments
- 17.1.19.4. Sales Footprint
- 17.1.19.5. Strategy Overview
- 17.1.19.5.1. Marketing Strategy
- 17.1.19.5.2. Product Strategy
- 17.1.19.5.3. Channel Strategy
- 17.1.20. WISAP Medical Technology
- 17.1.20.1. Overview
- 17.1.20.2. Product Portfolio
- 17.1.20.3. Profitability by Market Segments
- 17.1.20.4. Sales Footprint
- 17.1.20.5. Strategy Overview
- 17.1.20.5.1. Marketing Strategy
- 17.1.20.5.2. Product Strategy
- 17.1.20.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology